KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,033 | -9.1% | 6,500,000 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $4,436 | -61.9% | 6,500,000 | -56.7% | 0.01% | -66.7% |
Q1 2023 | $11,628 | -33.4% | 15,000,000 | -34.8% | 0.02% | -37.5% |
Q4 2022 | $17,453 | -99.9% | 23,000,000 | +1.6% | 0.02% | -11.1% |
Q3 2022 | $18,285,000 | +42.1% | 22,627,000 | +29.3% | 0.03% | +58.8% |
Q2 2022 | $12,872,000 | -41.3% | 17,500,000 | -32.4% | 0.02% | -32.0% |
Q1 2022 | $21,935,000 | +19.3% | 25,890,000 | +15.1% | 0.02% | +25.0% |
Q4 2021 | $18,393,000 | +25.3% | 22,500,000 | +15.4% | 0.02% | +17.6% |
Q3 2021 | $14,675,000 | -16.4% | 19,500,000 | +11.4% | 0.02% | -15.0% |
Q2 2021 | $17,552,000 | -24.7% | 17,500,000 | -22.2% | 0.02% | -28.6% |
Q1 2021 | $23,319,000 | +12.2% | 22,500,000 | +36.4% | 0.03% | +7.7% |
Q4 2020 | $20,780,000 | +24.1% | 16,500,000 | +17.9% | 0.03% | +8.3% |
Q3 2020 | $16,739,000 | -8.1% | 14,000,000 | +7.7% | 0.02% | -14.3% |
Q2 2020 | $18,219,000 | +5.9% | 13,000,000 | +8.3% | 0.03% | -12.5% |
Q1 2020 | $17,196,000 | +50.4% | 12,000,000 | +50.0% | 0.03% | +100.0% |
Q4 2019 | $11,435,000 | – | 8,000,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |